(Q39167915)

9 September 2017

Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo (English)

1 reference

9 September 2017

0 references

1 reference

3

Shingo Matsumoto

1 reference

9 September 2017

7

Kiyotaka Yoh

1 reference

9 September 2017

8

Koichi Goto

1 reference

9 September 2017

16

Katsuya Tsuchihara

1 reference

9 September 2017

15

Hiroyasu Esumi

1 reference

9 September 2017

5

Sachiyo Mimaki

1 reference

9 September 2017

14

Takashi Kohno

1 reference

9 September 2017

11

Atsushi Ochiai

1 reference

9 September 2017

10

Genichiro Ishii

1 reference

9 September 2017

13

Tatsuhiro Shibata

1 reference

9 September 2017

12

Koji Tsuta

1 reference

9 September 2017

2

Hideki Makinoshima

1 reference

9 September 2017

Makito Suzuki

1

1 reference

9 September 2017

Ayako Suzuki

series ordinal

4

1 reference

9 September 2017

Koutatsu Matsushima

series ordinal

6

1 reference

9 September 2017

Yutaka Suzuki

series ordinal

9

1 reference

9 September 2017

12 May 2013

1 reference

9 September 2017

1 reference

9 September 2017

104

1 reference

9 September 2017

896-903

1 reference

9 September 2017

7

1 reference

describes a project that uses

9 September 2017

LC-2/ad

0 references

cites work

Global cancer statistics

1 reference

New driver mutations in non-small-cell lung cancer

21 January 2018

1 reference

Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer

21 January 2018

1 reference

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

Erlotinib in lung cancer - molecular and clinical predictors of outcome

21 January 2018

1 reference

Genomic landscape of non-small cell lung cancer in smokers and never-smokers

21 January 2018

1 reference

Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing

21 January 2018

1 reference

The transcriptional landscape and mutational profile of lung adenocarcinoma.

21 January 2018

1 reference

KIF5B-RET fusions in lung adenocarcinoma.

21 January 2018

1 reference

Identification of RET gene fusion by exon array analyses in "pan-negative" lung cancer from never smokers

21 January 2018

1 reference

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

21 January 2018

1 reference

RET, ROS1 and ALK fusions in lung cancer

21 January 2018

1 reference

RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer.

21 January 2018

1 reference

Localisation of the gene for multiple endocrine neoplasia type 2A to a 480 kb region in chromosome band 10q11.2.

21 January 2018

1 reference

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

21 January 2018

1 reference

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

21 January 2018

1 reference

Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2/ad

21 January 2018

1 reference

PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma

21 January 2018

1 reference

Comprehensive histologic analysis of ALK-rearranged lung carcinomas

21 January 2018

1 reference

A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.

21 January 2018

1 reference

A gene-alteration profile of human lung cancer cell lines.

21 January 2018

1 reference

Targeting RET receptor tyrosine kinase activation in cancer

21 January 2018

1 reference

RET TKI: potential role in thyroid cancers.

21 January 2018

1 reference

AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines

21 January 2018

1 reference

Chemical genetic discovery of targets and anti-targets for cancer polypharmacology

21 January 2018

1 reference

Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas

21 January 2018

1 reference

12 December 2020

Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo

1 reference

12 December 2020

Establishment and characterization of a human lung adenocarcinoma cell line (LC-2/ad) producing alpha 1-antitrypsin in vitro.

1 reference

12 December 2020

Potential role of multi-targeted tyrosine kinase inhibitors in non-small-cell lung cancer

1 reference

12 December 2020

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.

1 reference

12 December 2020

Genetic linkage studies map the multiple endocrine neoplasia type 2 loci to a small interval on chromosome 10q11.2

1 reference

12 December 2020

Identifiers

DOI

10.1111/CAS.12175

1 reference

9 September 2017

0 references

1 reference